Study guide
14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration
COPR Primary Care Paramedic PCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The COPR PCP Exam & How to Use This Guide
0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan
2 Chapter 1: Professionalism, Ethics & Legal Framework
1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent
3 Chapter 2: Patient-Centred Communication & Clinical Documentation
2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans
4 Chapter 3: Interprofessional Collaboration & Continuum of Care
3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans
5 Chapter 4: Evidence-Informed Practice & Continuing Competence
4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession
6 Chapter 5: Professional Health, Safety & Operational Resilience
5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice
7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care
6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation
8 Chapter 7: Situational Leadership & Scene Operations
7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems
9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness
8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources
10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs
9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment
11 Chapter 10: Diagnostic Monitoring: ECG & Capnography
10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics
12 Chapter 11: Airway Management & Ventilation Therapeutics
11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy
13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care
12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine
14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR
13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation
15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies
14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies
16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation
15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting
17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients
16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities
18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology
17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States
19 Chapter 18: Pharmacology & Safe Medication Administration
18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration
20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement
19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care
21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use
20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction
14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration
Key Takeaways Explain This Topic AI
Acute hypoglycemia (capillary blood glucose <4.0 mmol/L) produces both autonomic/adrenergic signs (diaphoresis, tremors, tachycardia) and life-threatening neuroglycopenic deficits (confusion, focal stroke mimics, seizures, coma).
Conscious hypoglycemic patients with intact swallowing reflexes receive 15–20 g of oral glucose gel; unconscious or compromised patients require IV Dextrose (titrated 10% Dextrose in Water [D10W] 100–250 mL / 10–25 g is preferred over hypertonic D50W).
Intramuscular Glucagon (1 mg IM) stimulates hepatic glycogenolysis when IV access cannot be obtained, but is ineffective in patients with depleted glycogen stores (chronic alcoholism, malnutrition, prolonged starvation).
Diabetic Ketoacidosis (DKA) is caused by absolute insulin deficiency, marked by hyperglycemia, ketosis, high anion gap metabolic acidosis, and Kussmaul respirations; Hyperosmolar Hyperglycemic State (HHS) involves relative insulin deficiency with severe hyperglycemia (>33.3 mmol/L), extreme hyperosmolality, and profound dehydration without significant ketosis.
Prehospital management for both DKA and HHS prioritizes aggressive isotonic crystalloid fluid resuscitation (1 L normal saline bolus) to restore circulating volume and organ perfusion; prehospital insulin administration is strictly contraindicated.
Last updated: September 2026
- 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration
- Physiology of Glucose Regulation & Cellular Metabolism
Glucose is the primary obligate metabolic fuel for the human central nervous system. The brain consumes approximately 120 grams of glucose daily (accounting for ~60% of total whole-body glucose utilization at rest). Because cerebral neurons cannot synthesize glucose, store glycogen in significant quantities, or utilize free fatty acids for energy, uninterrupted neurological function depends on continuous circulating blood glucose maintenance within a tight physiological range ( 4.0 to 7.0 mmol/L [72 to 126 mg/dL] fasting).
Endocrine homeostasis is maintained by pancreatic islets of Langerhans:
Beta Cells & Insulin: High plasma glucose triggers insulin secretion. Insulin is an anabolic hormone that binds tyrosine kinase receptors, mobilizing GLUT4 glucose transporters to cell membranes in skeletal muscle and adipose tissue. It stimulates glycogenesis, lipogenesis, and protein synthesis while potently inhibiting glycogenolysis, gluconeogenesis, lipolysis, and ketogenesis .
Alpha Cells & Glucagon: Hypoglycemia suppresses insulin and stimulates glucagon release. Glucagon binds G-protein coupled receptors in hepatocytes, activating adenylyl cyclase to elevate cAMP and protein kinase A. This stimulates hepatic glycogenolysis (hydrolysis of stored glycogen into glucose) and gluconeogenesis (synthesis of glucose from lactate, glycerol, and amino acids), raising circulating blood glucose levels.
Acute Hypoglycemia: Neuroglycopenia vs Adrenergic Surges
Under Canadian paramedic clinical guidelines (CPCF Appendix A #4, #5), acute hypoglycemia is defined as a capillary blood glucose reading <4.0 mmol/L (<72 mg/dL) accompanied by characteristic clinical signs.
Clinical Presentation: Adrenergic vs Neuroglycopenic Signs
As plasma glucose drops, two distinct physiological cascades occur:
Autonomic / Adrenergic Signs (Threshold: <3.8 to 3.3 mmol/L): Initiated by a massive sympathoadrenal surge of epinephrine, norepinephrine, and acetylcholine designed to alert the individual to feed and stimulate hepatic glucose release. Signs include diaphoresis, pallor, piloerection, tremors, tachycardia, palpitations, anxiety, and intense hunger (polyphagia) . Note: Patients receiving non-selective beta-blockers (e.g., propranolol) or those with long-standing diabetes suffering from hypoglycemia unawareness (autonomic neuropathy) will not mount these warning adrenergic signs.
Neuroglycopenic Signs (Threshold: <2.8 mmol/L): Direct cellular fuel starvation of cerebral cortical and subcortical neurons. Manifests as irritability, behavioral changes, confusion, drowsiness, ataxia, visual disturbances, seizures, coma, and focal neurological deficits (hemiparesis, aphasia) that perfectly mimic acute ischemic stroke.
Important
The Stroke Mimic Rule: Every patient presenting with altered mental status, confusion, acute focal neurological deficits, or seizures must receive an immediate point-of-care capillary blood glucose measurement . Hypoglycemia is the single most common reversible stroke mimic in prehospital care. Transporting a hypoglycemic patient under a stroke bypass protocol without checking blood glucose is a critical clinical error.
Prehospital Pharmacotherapy for Hypoglycemia
Paramedics employ a tiered pharmacological approach tailored to the patient's level of consciousness and airway protective reflexes: Hypoglycemia Prehospital Decision Tree (Blood Glucose <4.0 mmol/L):
1. Conscious, Alert, Intact Gag & Swallow Reflex:
-> Administer 15–20 g of Oral Glucose Gel (or equivalent fast-acting carbohydrates).
-> Recheck blood glucose in 15 minutes.
2. Altered Mental Status, Impaired Swallowing, Unconscious, or IV Access Available:
-> First-Line: 10% Dextrose in Water (D10W) 100–250 mL (10–25 g) IV titrated infusion.
-> Alternative: 50% Dextrose in Water (D50W) 25–50 mL (12.5–25 g) slow IV push in large vein.
3. Altered Mental Status / Unconscious AND IV Access Cannot Be Established:
-> Administer Glucagon 1.0 mg IM (0.5 mg in pediatrics <20 kg).
-> Continue attempts at IV access while awaiting glucagon action (8–15 minutes).
1. Oral Glucose Gel
Dose: 15 to 20 grams orally.
Requirement: The patient must be awake, cooperative, able to sit upright, and demonstrate a preserved swallow reflex. It is administered by having the patient swallow the gel or by applying it to the buccal mucosa if conscious. Never administer oral agents to an obtunded patient due to severe aspiration pneumonia risks.
2. Intravenous Dextrose: D10W vs D50W
10% Dextrose in Water (D10W): Modern Canadian paramedic protocols strongly favor D10W over D50W. D10W provides 10 grams of dextrose per 100 mL. Paramedics infuse 100 mL to 250 mL (10 to 25 g) titrated to mental status recovery.
Why D10W is Superior: D50W is extremely hypertonic (~2,525 mOsm/L), whereas D10W has an osmolarity of ~505 mOsm/L. Extravasation of D50W into subcutaneous tissue causes severe chemical irritation, tissue necrosis, compartment syndrome, and ulceration requiring surgical grafting. Furthermore, D50W inflicts sudden hyperosmolar spikes, rebound hyperglycemia, and post-treatment hypoglycemia, whereas D10W allows gentle, controlled titration to normoglycemia.
50% Dextrose in Water (D50W): Administered as 25 to 50 mL (12.5 to 25 g) via slow IV push. Requires a free-flowing, large-bore intravenous catheter with mandatory continuous blood aspiration before and during administration to guarantee intravascular placement.
3. Intramuscular Glucagon
Dose: 1.0 mg IM for adults (0.5 mg for pediatrics <20 kg).
Mechanism: Stimulates hepatic adenylate cyclase to convert stored liver glycogen into glucose (glycogenolysis).
Critical Limitations: Glucagon relies entirely on pre-existing hepatic glycogen reserves . It is clinically ineffective in patients suffering from:
Chronic alcohol use disorder (alcohol metabolism blocks gluconeogenesis and depletes liver glycogen).
Severe malnutrition, cachexia, or prolonged fasting.
Advanced end-stage liver cirrhosis.
Neonates and infants with limited glycogen stores.
Furthermore, glucagon requires 8 to 15 minutes to elevate blood glucose, unlike intravenous dextrose which acts within 1 to 3 minutes.
Diabetic Ketoacidosis (DKA) vs Hyperosmolar Hyperglycemic State (HHS)
Severe decompensated hyperglycemia represents a continuum of life-threatening metabolic crises arising from absolute or relative insulin deficiency.
Clinical Parameter Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
Patient Population Classically Type 1 Diabetes Mellitus (can occur in severe Type 2 under extreme stress). Classically older adults with Type 2 Diabetes Mellitus; often institutionalized or bed-bound.
Hormonal Defect Absolute insulin deficiency + elevated glucagon, cortisol, and catecholamines. Relative insulin deficiency (sufficient insulin to suppress lipolysis, but not glucose uptake).
Serum Glucose Marked hyperglycemia: typically 14.0 to 30.0 mmol/L (250–550 mg/dL). Extreme, profound hyperglycemia: typically >33.3 to 60.0+ mmol/L (>600–1200 mg/dL).
Acid-Base & Ketosis Severe high anion gap metabolic acidosis (pH < 7.30, HCO3 < 15 mmol/L). Massive ketonemia/ketonuria. No significant acidosis (pH > 7.30, HCO3 > 18 mmol/L). Minimal or absent ketones.
Serum Osmolality Variable, usually <320 mOsm/kg. Profound hyperosmolality: typically >320 mOsm/kg .
Fluid Deficit Significant dehydration: 5 to 8 Litres (~100 mL/kg). Catastrophic dehydration: 8 to 12 Litres (~150–200 mL/kg).
Respiratory Pattern Kussmaul respirations: Rapid, deep, sighing hyperventilation; fruity acetone breath. Shallow, rapid respirations; NO Kussmaul breathing and no fruity breath.
Neurological State Alert, lethargic, or mildly drowsy; coma occurs in <10% (only if severe acidosis). Marked neurological impairment: delirium, lethargy, stupor, focal deficits, seizures, coma.
Precipitating Factors Insulin omission/pump failure, infection (pneumonia, UTI), myocardial infarction, new-onset diabetes. Severe acute infection (sepsis, pneumonia), stroke, myocardial infarction, poor fluid intake.
Pathophysiological Cascades: Ketogenesis vs Hyperosmolality
DKA Ketogenesis Cascade: In absolute insulin deficiency, glucose cannot enter peripheral cells. The body perceives cellular starvation and unleashes unrestrained lipolysis via hormone-sensitive lipase. Adipose tissue floods the liver with free fatty acids. In the liver, glucagon accelerates carnitine palmitoyltransferase-1 (CPT-1) activity, shunting fatty acids into mitochondrial beta-oxidation to produce excessive ketone bodies: beta-hydroxybutyrate and acetoacetate . These organic ketoacids dissociate, releasing hydrogen ions that overwhelm bicarbonate buffering, creating severe metabolic acidosis. Acetone is excreted via the lungs, generating a distinct fruity or sweet breath odor .
Kussmaul Respirations: The medullary respiratory center senses severe metabolic acidosis (pH < 7.20) via central and peripheral chemoreceptors. The patient mounts profound, rapid, deep hyperventilation ( Kussmaul breathing ) to eliminate carbon dioxide (PaCO2 < 20 mmHg), achieving compensatory respiratory alkalosis.
HHS Hyperosmolar Cascade: Patients with Type 2 diabetes maintain minute residual basal insulin concentrations. While insufficient to facilitate skeletal muscle glucose uptake, this trace insulin is biochemically adequate to suppress adipose lipolysis and inhibit hepatic ketogenesis . Therefore, no significant ketoacidosis develops. Instead, uncontrolled hepatic gluconeogenesis drives plasma glucose to extreme levels (>33–60 mmol/L). Elevated glucose exceeds the renal reabsorption threshold (~10 mmol/L), producing massive osmotic diuresis (glucosuria) , washing out vast volumes of water and electrolytes (sodium, potassium, magnesium). As water loss exceeds solute loss, serum osmolality climbs (>320 mOsm/kg), drawing water out of brain cells and causing profound dehydration and coma.
Prehospital Resuscitation Principles for DKA & HHS
Paramedics provide life-saving hemodynamic stabilization for both DKA and HHS focusing on fluid resuscitation:
Isotonic Crystalloid Fluid Resuscitation: The foundational prehospital intervention is intravenous 0.9% Normal Saline . Massive osmotic diuresis collapses intravascular volume, impairing renal perfusion and creating pre-renal azotemia. Paramedics administer an initial 1,000 mL bolus of normal saline over the first hour (or 10 to 20 mL/kg in pediatrics), followed by continuous reassessment of breath sounds, heart rate, and blood pressure to detect fluid overload.
Strict Prohibition of Prehospital Insulin: Primary care paramedics do NOT administer insulin in the field. Rapid prehospital insulin administration causes two lethal physiological disasters:
Catastrophic Hypokalemia: Insulin drives potassium into cells via the Na+/K+ ATPase pump. In DKA, total body potassium is severely depleted due to osmotic diuresis, even if serum potassium appears normal or elevated on initial lab work (due to extracellular shifting from acidosis). Injecting insulin without laboratory electrolyte confirmation and potassium replacement triggers sudden, fatal cardiac arrest from ventricular fibrillation or asystole.
Cerebral Edema: Rapid reductions in blood glucose drop plasma osmolality faster than brain idiogenic osmoles can dissipate. Water rushes down the osmotic gradient into brain parenchymal cells, causing fatal cerebral herniation, particularly in pediatric DKA patients.
Preserving Compensatory Hyperventilation: Paramedics must recognize that rapid, deep Kussmaul respirations in DKA are a vital compensatory mechanism to blow off CO2. Paramedics must never attempt to suppress this breathing or administer sedatives/narcotics , as blunting the respiratory rate traps CO2, causing profound acute drop in blood pH (pH < 6.9) and cardiac arrest.
Clinical Scenario: Hypoglycemic Stroke Mimic vs DKA
Paramedics respond to a 58-year-old male with Type 1 diabetes whose spouse called 911 reporting he is 'acting completely drunk, slurring his speech, and cannot move his right arm'.
Initial Presentation: The patient is seated at the kitchen table, pale, profusely diaphoretic, and confused. He is disoriented to time and place, has an asymmetrical right facial droop, and cannot raise his right arm against gravity. Initial thought by first responders is acute ischemic stroke.
Mandatory Glucometry: Prior to initiating any stroke bypass, the primary care paramedic performs a point-of-care capillary blood glucose test. The glucometer reads 'LOW' (<1.1 mmol/L) .
Targeted Pharmacotherapy: The patient cannot follow commands or swallow safely, ruling out oral glucose gel. Paramedic 1 establishes an 18-gauge IV in the left forearm. Rather than administering hypertonic D50W, the paramedic connects a bag of 10% Dextrose in Water (D10W) and infuses 150 mL (15 grams of dextrose) over 5 minutes.
Rapid Reversal: Four minutes into the infusion, the diaphoresis resolves. The patient blinks, looks around, and asks what the paramedics are doing in his kitchen. Repeat physical examination reveals full resolution of the facial droop and equal 5/5 motor strength in both arms. Repeat capillary blood glucose is 5.4 mmol/L .
Post-Treatment Investigation: The patient recalls injecting his usual morning insulin but was delayed in eating breakfast due to a long phone call. The paramedic provides complex carbohydrates, conducts a full medical assessment, and safely transports the patient for clinical evaluation, having avoided an unnecessary and costly stroke bypass code.